Pneumococcal Conjugate Vaccine Appears to Reduce Pneumonia, Serious Complications in Infants: Research

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research
A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine’s target range, children less than a year old, according to new research.
Read more on News-Medical-Net